Correlation Between Passage Bio and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Passage Bio and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Day One.

Diversification Opportunities for Passage Bio and Day One

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Passage and Day is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Passage Bio i.e., Passage Bio and Day One go up and down completely randomly.

Pair Corralation between Passage Bio and Day One

Given the investment horizon of 90 days Passage Bio is expected to generate 2.45 times more return on investment than Day One. However, Passage Bio is 2.45 times more volatile than Day One Biopharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest  58.00  in Passage Bio on August 24, 2024 and sell it today you would lose (4.00) from holding Passage Bio or give up 6.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Passage Bio  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Passage Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Passage Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Passage Bio and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Passage Bio and Day One

The main advantage of trading using opposite Passage Bio and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Passage Bio and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges